Note 18 - Subsequent Events |
6 Months Ended |
|---|---|
Jun. 30, 2026 | |
| Notes to Financial Statements | |
| Subsequent Events [Text Block] |
We have evaluated subsequent events through the time of filing on the date we have issued this Quarterly Report on Form 10-Q.
On July 31, 2026, the USDA approved an extension of expiration limits for colostrum used in the production of First Defense®. As of June 30, 2026, we had reserved $233,665 for colostrum then considered obsolete. We expect to release this reserve to costs of goods sold in the three months ended September 30, 2026, though the total impact to our financial statements is not currently reasonably estimable due to unknown yield expectations and the timing of eventual sales.
No other subsequent events were identified.
|